Multi-institutional retrospective study of mucoepidermoid carcinoma treated with carbon-ion radiotherapy

the Japan Carbon-Ion Radiation Oncology Study Group

研究成果: Contribution to journalArticle

13 引用 (Scopus)

抜粋

This study aimed to evaluate the clinical outcomes of patients with mucoepidermoid carcinomas in the head and neck treated with carbon-ion radiotherapy. Data from 26 patients who underwent carbon-ion radiotherapy in four facilities were analyzed in this multi-institutional retrospective study: the Japan Carbon-ion Radiation Oncology Study Group. The median follow-up time was 34 months. One patient experienced local recurrence, and the 3-year local control rate was 95%. One patient developed lymph node recurrence and five developed distant metastases. The 3-year progression-free survival rate was 73%. Five patients died, two of mucoepidermoid carcinoma and three of intercurrent disease. The 3-year overall survival rate was 89%. Acute mucositis and dermatitis of grade 3 or higher were experienced by 19% and 8% of patients, respectively; these improved with conservative therapy. Late mucositis and osteonecrosis of jaw were observed in 12% and 23% of patients, respectively. The 3-year cumulative rate of any late adverse event of grade 3 or higher was 14%. None of the patients died of the acute or late adverse events. Carbon-ion radiotherapy was efficacious and safe for treating mucoepidermoid carcinoma in this multi-institutional retrospective study (registration no. UMIN000024473). We are currently undertaking a prospective multicenter study.

元の言語英語
ページ(範囲)1447-1451
ページ数5
ジャーナルCancer Science
108
発行部数7
DOI
出版物ステータス出版済み - 7 2017

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

フィンガープリント Multi-institutional retrospective study of mucoepidermoid carcinoma treated with carbon-ion radiotherapy' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用